WPI 3293 (Telmisartan 40 mg)

Pill imprint WPI 3293 has been identified as Telmisartan 40 mg.

Telmisartan is used in the treatment of high blood pressure; cardiovascular risk reduction; prevention of cardiovascular disease and belongs to the drug class angiotensin receptor blockers. There is positive evidence of human fetal risk during pregnancy. Telmisartan 40 mg is not a controlled substance under the Controlled Substance Act (CSA).

Telmisartan

Imprint:

WPI 3293

Strength:

40 mg

Color:

White

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Angiotensin receptor blockers

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Watson Laboratories, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.